# Trinity: The Commercialization Intelligence Partner for Life Sciences

> Accelerate drug launches with proven AI solutions, expert insights and 30 years expertise\. Trusted by 350\+ life sciences leaders\.

Generated by Yoast SEO v28.5, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [About Us](https://trinitylifesciences.com/company/)
- [Contact Us](https://trinitylifesciences.com/contact/)
- [Privacy Policy](https://trinitylifesciences.com/website-privacy-policy/)
- [Trinity AI](https://trinitylifesciences.com/services/trinity-ai/)
- [Outcomes We Drive](https://trinitylifesciences.com/outcomes-we-drive/)
- [Biotech](https://trinitylifesciences.com/services/industry/biotech/)
- [Pharma](https://trinitylifesciences.com/services/industry/pharma/)
- [MedTech](https://trinitylifesciences.com/services/industry/medtech/)
- [Pipeline \& Pre\-Commercial](https://trinitylifesciences.com/services/commercialization-stage/pipeline-and-precommercial/)
- [Launch Planning \& Execution](https://trinitylifesciences.com/solutions/launch-planning-execution/)
- [Brand Optimization](https://trinitylifesciences.com/services/commercialization-stage/brand-optimization/)

## Posts
- [Beyond the ICD Code: Why Patient Finding Must Lead to Commercial Action](https://trinitylifesciences.com/blog/icd-code-patient-finding-commercial-action/): For years, the life sciences industry has invested heavily in finding patients earlier, more accurately, and at greater scale\. As data sources expand and machine learning models improve, patient\-finding programs have become more sophisticated\. A new generation of AI capabilities now promises to unlock signals from clinical notes, referral pathways, genomic data, and other sources that traditional approaches have historically struggled to incorporate\.
- [From Insights to Impact: How AI Is Transforming Pharmaceutical Competitive Intelligence](https://trinitylifesciences.com/blog/how-ai-is-transforming-pharmaceutical-competitive-intelligence/): Pharmaceutical competitive intelligence \(CI\) has quietly become one of pharma’s most strained functions\. The TGaS Competitive Intelligence Landscape Survey \(October 2025\) shows competitive complexity accelerating at a pace that traditional CI models cannot absorb\.
- [From Research Delivery to Decision Orchestration: The Next Evolution of PMR](https://trinitylifesciences.com/blog/pmr-research-delivery-to-decision-orchestration/): Primary market research \(PMR\) has long been a trusted advisor to brand teams, helping organizations understand customers, test assumptions, and reduce uncertainty in critical business decisions\. Over the past decade, however, many PMR organizations have been asked to do more with less\. 
- [What NRDL 2025 Outcomes Mean for Drug Pricing and Market Access in China](https://trinitylifesciences.com/blog/nrdl-2025-drug-pricing-market-access-china/): China's reimbursement environment changed with the introduction of the NRDL value rating framework in 2023 and the Commercial Insurance Innovative Drug List \(CIIDL\) in 2025\. NRDL 2025 outcomes show that payers continue rewarding breakthrough therapies, comparative evidence, and treatments for unmet need\. This article examines how clinical evidence, therapeutic differentiation, patient population size, and pricing expectations shaped 2025 NRDL and CIIDL outcomes\.
- [How AI and Patient\-Level Data Help Oncology Teams Define New Markets](https://trinitylifesciences.com/blog/how-ai-and-patient-level-data-help-oncology-teams/): Oncology markets are no longer defined only by tumor type or line of therapy\. AI, patient\-level data, and primary research now help teams define markets by biology, care pathways, and access barriers\. That shift can shape development strategy, trial design, and commercialization plans much earlier in the asset lifecycle\.

## Testimonials
- [First Launch Biotech](https://trinitylifesciences.com/testimonial/sample-3/)
- [Launch in Big Pharma](https://trinitylifesciences.com/testimonial/sample-2-2/)

## Events
- [AI for Impact: Incentive Compensation Best Practices](https://trinitylifesciences.com/learn-and-connect/events/ai-for-impact-incentive-compensation-best-practices/)
- [Next\-Generation Launch Forum Series](https://trinitylifesciences.com/learn-and-connect/events/next-generation-launch-forum-series/)
- [Pharma Competitive Intelligence](https://trinitylifesciences.com/learn-and-connect/events/pharma-competitive-intelligence/)
- [TGaS Fall Client Summit](https://trinitylifesciences.com/learn-and-connect/events/tgas-fall-client-summit/)
- [2026 PMSA Fall Symposium](https://trinitylifesciences.com/learn-and-connect/events/2026-pmsa-fall-symposium/)

## Leadership
- [Whitney Hanson](https://trinitylifesciences.com/company/leadership/whitney-hanson/)
- [Tina Durocher\-Murphy](https://trinitylifesciences.com/company/leadership/tina-durocher-murphy/)
- [Colin Boatwright](https://trinitylifesciences.com/company/leadership/colin-boatwright/)
- [Sutton Faller](https://trinitylifesciences.com/company/leadership/sutton-faller/)
- [Miguel Martin de Bustamante](https://trinitylifesciences.com/company/leadership/miguel-martin-de-bustamante/)

## News
- [Drugmakers Turn to AI to Navigate Asia's Fragmented Healthcare Markets](https://www.ibtimes.sg/drugmakers-turn-ai-navigate-asias-fragmented-healthcare-markets-93622/): For global life sciences companies looking to Asia for growth, one of the biggest challenges is also one of the region's defining characteristics: There is no single Asian healthcare market\.
China, Japan, South Korea, Singapore and India are pursuing different approaches to drug pricing, reimbursement and healthcare innovation, complicating efforts by multinational drugmakers to bring new treatments to patients across the region\.
- [How Direct\-to\-Consumer Healthcare Is Reshaping the Pharmaceutical Industry](https://www.techtimes.com/articles/328892/20261010/how-direct-consumer-healthcare-reshaping-pharmaceutical-industry.htm): For decades, the pharmaceutical industry has operated through a complex network of physicians, insurers, pharmacy benefit managers, and retail pharmacies\. Patients seeking prescription medications typically navigated a system in which access, pricing, and fulfillment were largely determined by intermediaries\.
- [AI Is Moving Pharma Commercialization from Prediction to Simulation](https://trinitylifesciences.com/company/news/ai-is-moving-pharma-commercialization-from-prediction-to-simulation/)
- [Leading through complexity: How Trinity Life Sciences CEO Scott Evangelista is redefining strategy in the age of AI](https://trinitylifesciences.com/company/news/leading-through-complexity-how-trinity-life-sciences-ceo-scott-evangelista-is-redefining-strategy-in-the-age-of-ai/)
- [How AI Is Reshaping Commercial Decision\-Making in Life Sciences](https://trinitylifesciences.com/company/news/how-ai-is-reshaping-commercial-decision-making-in-life-sciences/)

## Press Releases
- [Trinity Acquires Verix, Adding AI\-Powered Next\-Best\-Action and Omnichannel Orchestration to the TrinityEDGE Platform](https://trinitylifesciences.com/company/press-releases/trinity-acquires-verix/)
- [Trinity Life Sciences Recapitalizes With Kohlberg \& Company](https://trinitylifesciences.com/company/press-releases/trinity-life-sciences-recapitalizes-with-kohlberg-company/)
- [Trinity Life Sciences Acquires Vancery’s Customer Research Technology](https://trinitylifesciences.com/company/press-releases/trinity-life-sciences-acquires-vancerys-customer-research-technology/)
- [Trinity Life Sciences Acquires CBPartners](https://trinitylifesciences.com/company/press-releases/trinity-life-sciences-acquires-cbpartners/)
- [Trinity Life Sciences Acquires Blueprint Research Group](https://trinitylifesciences.com/company/press-releases/trinity-life-sciences-acquires-blueprint-research-group/)

## Resources
- [How AI Is Transforming Pharma Commercialization \| Trinity Life Sciences CEO](https://trinitylifesciences.com/resources/ntts-scott-evangelista/)
- [5th Annual Next Gen Launch Report](https://trinitylifesciences.com/white-papers/5th-annual-next-gen-launch-report/): 2025 Launch Paradox: Ambiguity, Overperformance, and What Standouts from the Class of 2025 Teach Us About Launch Excellence in Uncertain Markets
- [AI Readiness in Life Sciences: How Do You Measure Up?](https://trinitylifesciences.com/webinars/ai-readiness-in-life-sciences/): Life sciences organizations are moving beyond isolated AI pilots toward enterprise\-wide initiatives that span commercial, medical, data, and field operations\. Yet many teams are investing in AI without a clear understanding of their readiness, governance requirements, strategic priorities, or how their progress compares to peers\. This webinar will explore practical approaches to assessing AI readiness, benchmarking your organization’s capabilities against industry peers, and identifying priorities for the next 12\-18 months\.
- [Effective Sales Contests: Purposes, Pitfalls, and Best Practices for Incentive Compensation Teams](https://trinitylifesciences.com/resources/effective-sales-contests-incentive-compensation/)
- [AI for Impact: Incentive Compensation Best Practices](https://trinitylifesciences.com/webinars/ai-for-impact-incentive-compensation/)

## Solution Cards
- [Asia Pacific](https://trinitylifesciences.com/?solution_card=asia-pacific)
- [Middle East \& North Africa](https://trinitylifesciences.com/?solution_card=middle-east-north-africa)
- [Latin America](https://trinitylifesciences.com/?solution_card=latin-america)
- [Europe](https://trinitylifesciences.com/?solution_card=europe)
- [United States](https://trinitylifesciences.com/?solution_card=united-states)

## Categories
- [Blog](http://trinitylifesciences.com/blog/category/blog/)
- [Market Access Trends 2026](http://trinitylifesciences.com/blog/category/blog/market-access-trends-2026/)
- [Trinity: Deep Dive](http://trinitylifesciences.com/blog/category/blog/trinity-deep-dive/)

## Tags
- [Direct\-to\-Consumer](http://trinitylifesciences.com/blog/tag/direct-to-consumer/)
- [Learning and Development](http://trinitylifesciences.com/blog/tag/learning-and-development/)
- [Patient Centricity](http://trinitylifesciences.com/blog/tag/patient-centricity/)
- [New Product Planning](http://trinitylifesciences.com/blog/tag/new-product-planning/)
- [Omnichannel](http://trinitylifesciences.com/blog/tag/omnichannel/)

## Post Series
- [2026 Market Access Trends](http://trinitylifesciences.com/blog/post-series/2026-market-access-trends/)
- [Trinity: Deep Dive](http://trinitylifesciences.com/blog/post-series/trinity-deep-dive/)

## Leadership Types
- [Board of Directors](http://trinitylifesciences.com/blog/leadership_type/board-of-directors/)
- [Board of Advisors](http://trinitylifesciences.com/blog/leadership_type/advisory-board/)
- [Leadership](http://trinitylifesciences.com/blog/leadership_type/leadership/)

## Resource Types
- [Webinars](http://trinitylifesciences.com/blog/resource_type/webinars/)
- [Briefs](http://trinitylifesciences.com/blog/resource_type/briefs/)
- [White Papers](http://trinitylifesciences.com/blog/resource_type/white-papers/)
- [Scientific Publications](http://trinitylifesciences.com/blog/resource_type/scientific-publications/)
- [Case Studies](http://trinitylifesciences.com/blog/resource_type/case-studies/)

## Event Types
- [Virtual](http://trinitylifesciences.com/blog/event_type/virtual/)

## Optional
- [Sitemap index](http://trinitylifesciences.com/sitemap_index.xml)